ATE556596T1 - Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion - Google Patents
Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktionInfo
- Publication number
- ATE556596T1 ATE556596T1 AT03721711T AT03721711T ATE556596T1 AT E556596 T1 ATE556596 T1 AT E556596T1 AT 03721711 T AT03721711 T AT 03721711T AT 03721711 T AT03721711 T AT 03721711T AT E556596 T1 ATE556596 T1 AT E556596T1
- Authority
- AT
- Austria
- Prior art keywords
- immmunity
- protective function
- live vaccines
- improve cross
- regulated attenuation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/255—Salmonella (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37261602P | 2002-04-15 | 2002-04-15 | |
| US37362602P | 2002-04-18 | 2002-04-18 | |
| PCT/US2003/011802 WO2003096812A1 (en) | 2002-04-15 | 2003-04-15 | Regulated attenuation of live vaccines to enhance cross protective immunogenicity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE556596T1 true ATE556596T1 (de) | 2012-05-15 |
Family
ID=29553427
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03721711T ATE556596T1 (de) | 2002-04-15 | 2003-04-15 | Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8133493B2 (de) |
| EP (2) | EP2380440B1 (de) |
| AT (1) | ATE556596T1 (de) |
| CA (1) | CA2526895A1 (de) |
| WO (1) | WO2003096812A1 (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2512812A1 (en) * | 2003-01-09 | 2004-07-29 | The Trustees Of The University Of Pennsylvania | Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| AU2004231129A1 (en) * | 2003-04-18 | 2004-10-28 | Warnex Research Inc. | Oligonucleotides for the detection of salmonella species |
| US8604178B2 (en) * | 2006-09-18 | 2013-12-10 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses |
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| EP2150616A4 (de) | 2007-05-10 | 2011-07-27 | Univ Arizona | Geregelte antigensynthese und/oder geregelte attenuation zur verbesserung der impfstoff immunogenität und/oder -sicherheit |
| EP2152883A4 (de) * | 2007-05-10 | 2010-10-27 | Univ Arizona | Rekombinante bakterien mit vektoren zur expression von nukleinsäuresequenzencodierenden antigenen |
| US8263088B2 (en) * | 2007-06-08 | 2012-09-11 | Australian Poultry Crc Pty Ltd. | Clostridial toxin NetB |
| US20090035815A1 (en) * | 2007-06-29 | 2009-02-05 | Laxmi Srinivas Rao | Synthetic Gene for Enhanced Expression in E. Coli |
| US9040059B2 (en) | 2007-10-05 | 2015-05-26 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting a protective immune response against C. perfringens |
| US9125854B2 (en) * | 2007-10-30 | 2015-09-08 | The Board Of Trustees Of The University Of Arkansas | Compositions and methods of enhancing immune responses to flagellated bacterium |
| PL3097926T3 (pl) * | 2007-11-01 | 2020-04-30 | The Board Of Trustees Of The University Of Arkansas | Kompozycje i sposoby wzmacniania odpowiedzi odpornościowych na Eimeria |
| WO2010045620A1 (en) * | 2008-10-17 | 2010-04-22 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium capable of eliciting an immune response against streptococcus pneumoniae |
| WO2010094699A1 (en) * | 2009-02-19 | 2010-08-26 | Creatogen Laboratories Gmbh | Attenuated salmonella enteritidis strain |
| US9163219B2 (en) * | 2009-04-14 | 2015-10-20 | Arizona Board Of Regents On Behalf Of Arizona State University | Single expression vector for generation of a virus with a segmented genome |
| US8709444B2 (en) | 2009-05-14 | 2014-04-29 | Northwestern University | Live-attenuated compositions for bacterial infections |
| GB2483595B (en) | 2009-05-22 | 2017-03-29 | The Arizona Board Of Regents For And On Behalf Of Arizona State Univ | Recombinant bacterium and methods of antigen and nucleic acid delivery |
| US9045742B2 (en) | 2009-05-29 | 2015-06-02 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant Edwardsiella bacterium |
| US9062297B2 (en) | 2010-01-13 | 2015-06-23 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Yersinia pestis vaccine |
| HUE037157T2 (hu) | 2010-01-21 | 2018-08-28 | Univ Arkansas | Vakcinavektorok, és eljárások immunválaszok fokozására |
| US8889121B2 (en) | 2010-01-22 | 2014-11-18 | The Arizona Board Of Regents For An On Behalf Of Arizona State University | Bacterium comprising a regulated rfaH nucleic acid |
| WO2011150421A2 (en) | 2010-05-28 | 2011-12-01 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Recombinant bacterium to decrease tumor growth |
| KR102008120B1 (ko) | 2010-06-09 | 2019-08-07 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 캄필로박터 감염을 감소시키기 위한 백신 및 방법 |
| WO2012003460A2 (en) | 2010-07-02 | 2012-01-05 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Compositions and methods for bacterial lysis and neutral lipid production |
| CN104159601B (zh) | 2012-02-01 | 2017-05-24 | 代表亚利桑那大学的亚利桑那董事会 | 弯曲杆菌属免疫原性组合物及其用途 |
| US9303264B2 (en) | 2012-05-18 | 2016-04-05 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Photosynthetic microorganisms expressing thermostable lipase |
| EA030929B1 (ru) | 2013-02-14 | 2018-10-31 | Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Арканзас | КОМПОЗИЦИИ И СПОСОБЫ УСИЛЕНИЯ ИММУННЫХ ОТВЕТОВ НА Eimeria ИЛИ ОГРАНИЧЕНИЯ ИНФЕКЦИИ Eimeria |
| BR112015023024B1 (pt) | 2013-03-15 | 2022-04-19 | The Board Of Trustees Of The University Of Arkansas | Vetor de vacina e composições farmacêuticas compreendendo o mesmo |
| US9580718B2 (en) | 2013-06-17 | 2017-02-28 | Arizona Board Of Regents On Behalf Of Arizona State University | Attenuated live bacteria with increased acid resistance and methods of use thereof |
| WO2015103104A1 (en) * | 2014-01-06 | 2015-07-09 | The United States Of America, As Represented By The Secretary Of Agriculture | Attenuated salmonella enterica |
| EP3122773B1 (de) * | 2014-03-27 | 2020-07-22 | Ghosh, Sambuddha | Expression eines einkettigen antikörpers gegen salmonellen in lactobacillus |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| TWI758288B (zh) | 2016-05-03 | 2022-03-21 | 阿肯色州大學董事會 | 包含免疫刺激性及抗原性多肽的酵母菌疫苗載體以及其使用方法 |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| CA3069523A1 (en) | 2017-07-11 | 2019-01-17 | Actym Therapeutics, Inc. | Engineered immunostimulatory bacterial strains and uses thereof |
| EP3820992A2 (de) * | 2018-07-11 | 2021-05-19 | Actym Therapeutics, Inc. | Manipulierte immunstimulierende bakterienstämme und verwendungen davon |
| EP3844276A2 (de) | 2018-08-28 | 2021-07-07 | Actym Therapeutics, Inc. | Manipulierte immunstimulierende bakterienstämme und verwendungen davon |
| US12024709B2 (en) | 2019-02-27 | 2024-07-02 | Actym Therapeutics, Inc. | Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment |
| WO2021222696A1 (en) * | 2020-04-30 | 2021-11-04 | University Of Florida Research Foundation, Incorporated | Live self-destructing bacterial adjuvants to enhance induction of immunity |
| US10973908B1 (en) | 2020-05-14 | 2021-04-13 | David Gordon Bermudes | Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine |
| US12537071B1 (en) | 2020-07-22 | 2026-01-27 | David Gordon Bermudes | Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins |
| CN112695004A (zh) * | 2020-12-28 | 2021-04-23 | 南通大学 | APEC双基因rpoS和arcA缺失菌株及弱毒疫苗 |
| WO2022271976A1 (en) * | 2021-06-24 | 2022-12-29 | Elanco Us Inc. | Attenuated salmonella, vaccines, and delivery platform |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4888170A (en) | 1981-10-22 | 1989-12-19 | Research Corporation | Vaccines obtained from antigenic gene products of recombinant genes |
| IL86583A0 (en) | 1987-06-04 | 1988-11-15 | Molecular Eng Ass | Vaccine containing a derivative of a microbe and method for the production thereof |
| US5294441A (en) | 1987-06-04 | 1994-03-15 | Washington University | Avirulent microbes and uses therefor: salmonella typhi |
| AU637969B2 (en) | 1987-10-07 | 1993-06-17 | Washington University | A method of maintaining a desired recombinant gene in a genetic population of cells |
| DE69027313T2 (de) | 1989-03-31 | 1997-01-23 | Univ Washington | Impfstoffe enthaltende avirulente phop-type mikroorganismen |
| GB8912330D0 (en) | 1989-05-30 | 1989-07-12 | Wellcome Found | Live vaccines |
| CA2072633A1 (en) * | 1989-11-03 | 1991-05-04 | Roy Curtiss Iii | Cross-protective salmonella vaccines |
| CA2143299A1 (en) | 1992-09-04 | 1994-03-17 | University Of Saskatchewan | Novel bacterial vaccines using vaccine strains of pathogenic bacteria |
| GB9711964D0 (en) | 1997-06-09 | 1997-08-06 | Medical Res Council | Live attenuated vaccines |
| US6024961A (en) | 1997-11-14 | 2000-02-15 | Washington University | Recombinant avirulent immunogenic S typhi having rpos positive phenotype |
| EP1064366A1 (de) * | 1998-03-20 | 2001-01-03 | Human Genome Sciences, Inc. | Gene und polypeptide von staphylococcus aureus. |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| US6399074B1 (en) * | 1998-07-24 | 2002-06-04 | Megan Health, Inc. | Live attenuated salmonella vaccines to control avian pathogens |
| US6713073B1 (en) | 1998-07-24 | 2004-03-30 | Megan Health, Inc. | Method of vaccination of newly hatched poultry |
| US6780405B1 (en) * | 2000-04-28 | 2004-08-24 | Avant Immunotherapeutics, Inc. | Regulated antigen delivery system (RADS) |
-
2003
- 2003-04-15 US US10/511,616 patent/US8133493B2/en not_active Expired - Lifetime
- 2003-04-15 AT AT03721711T patent/ATE556596T1/de active
- 2003-04-15 EP EP10181350.9A patent/EP2380440B1/de not_active Expired - Lifetime
- 2003-04-15 EP EP03721711A patent/EP1499191B1/de not_active Expired - Lifetime
- 2003-04-15 CA CA002526895A patent/CA2526895A1/en not_active Abandoned
- 2003-04-15 WO PCT/US2003/011802 patent/WO2003096812A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP2380440A1 (de) | 2011-10-26 |
| EP1499191A1 (de) | 2005-01-26 |
| WO2003096812A1 (en) | 2003-11-27 |
| CA2526895A1 (en) | 2003-11-27 |
| US8133493B2 (en) | 2012-03-13 |
| EP1499191A4 (de) | 2006-06-21 |
| US20060233829A1 (en) | 2006-10-19 |
| EP1499191B1 (de) | 2012-05-09 |
| EP2380440B1 (de) | 2016-03-09 |
| AU2003235457A1 (en) | 2003-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE556596T1 (de) | Regulierte attenuierung von lebendimpfstoffen zur verbesserung der kreuzimmunitätsschutzfunktion | |
| ATE549032T1 (de) | Adjuvanzverbindungen zur verbesserung von immunreaktionen auf polynukleotid-basierten impfstoffen | |
| ECSP11010975A (es) | Método de uso de una cepa de bacillus subtilis para mejorar la salud de animales | |
| ATE511398T1 (de) | Inaktiviertes poliovirus mischimpfstoff | |
| ATE451119T1 (de) | Untereinheit-impfstoff gegen das respiratorische synzytialvirus | |
| DE602004020189D1 (de) | Adjuvante influenza-vakzine | |
| TNSN07387A1 (en) | C.perfringens alpha toxoid vaccine | |
| ECSP077179A (es) | Co-cultivos manejados de organismos que tienen efectos profilacticos y promotores de la salud | |
| BR0316346A (pt) | Vacina para vìrus do nilo ocidental | |
| PT650733E (pt) | Vacina in ovo viva atenuada | |
| PT1112747E (pt) | Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos | |
| MX2010000864A (es) | Vacuna de celulas enteras estafilococcicas inactivadas. | |
| CY1112575T1 (el) | Βελτιωμενα αδρανοποιημενα εμβολια fcv | |
| DE602005012097D1 (de) | Adjuvante zusammensetzung und anwendungsverfahren dafür | |
| MA28268A1 (fr) | Composes et techniques de traitement de la dyslipidemie | |
| ATE270112T1 (de) | Streptococcus equi impfstoff | |
| DE602004006026D1 (de) | Streptococcus-phocae-vakzine | |
| TW200503755A (en) | Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella | |
| SG147465A1 (en) | Vaccine | |
| AR009650A1 (es) | Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna. | |
| DK1074266T3 (da) | Levende svækkede bakterier til anvendelse i vaccine | |
| AR041090A1 (es) | Uso de toxina labil al calor de esterichia coli como adyuvante en pajaros y aves de corral | |
| ATE540692T1 (de) | Verwendung von clostridium perfringens-typ c- bakterium zur herstellung eines impfstoffs | |
| ATE495757T1 (de) | Attenuierte bakterielle lebendvakzine | |
| ATE424844T1 (de) | Kombinationsvakzine für geflügel |